Netherlands - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes
Since 2014, Netherlands Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes rose 1% year on year. With €332.77 Per Capita in 2019, the country was number 18 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes. Netherlands is overtaken by Greece, which was ranked number 17 at €337.42 Per Capita and is followed by Denmark with €331.09 Per Capita. Switzerland lead the ranking with €1,048.7 Per Capita in 2019, +2.6% compared to 2018. Liechtenstein, Germany and Belgium respectively ranked number 2, 3 and 4 in this ranking. Latvia witnessed the best average annual growth at +7.4% per year, while Greece witnessed the worst performance at -0.5% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 332.77 |
| 2018 | 333.34 |
| 2017 | 329.81 |
| 2016 | 330.00 |
| 2015 | 325.18 |
How does Netherlands rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
1,048.70 | 2019 | +2.6 % | +4.7 % | View data | |
| 2 |
#2
Liechtenstein
|
860.32 | 2019 | +3.0 % | +2.4 % | View data | |
| 17 |
#17
Greece
|
337.42 | 2019 | -3.1 % | -0.5 % | View data | |
| 18 |
#18
Netherlands
|
332.77 | 2019 | -0.2 % | +1.0 % | View data | |
| 19 |
#19
Denmark
|
331.09 | 2019 | -1.6 % | +0.2 % | View data | |